Ken Fisher Clovis Oncology, Inc. Transaction History

Fisher Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$5.02 - $7.05 $75,611 - $106,187	-15,062 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$4.81 - $10.34 $155,059 - $333,330	-32,237 Reduced 68.16%	15,062 $106,000
Q4 2020 Jan 29, 2021	BUY	$4.13 - $6.41 $1,693 - $2,628	410 Added 0.87%	47,299 $227,000
Q3 2020 Nov 10, 2020	BUY	$4.82 - $7.72 $53 - $84	11 Added 0.02%	46,889 $273,000
Q2 2020 Aug 07, 2020	BUY	$5.69 - $9.69 $381 - $649	67 Added 0.14%	46,878 $316,000
Q1 2020 Apr 28, 2020	SELL	$3.77 - $11.0 $129,228 - $377,058	-34,278 Reduced 42.27%	46,811 $298,000
Q4 2019 Feb 12, 2020	SELL	$3.0 - $16.43 $117,561 - $643,842	-39,187 Reduced 32.58%	81,089 $845,000
Q2 2019 Jul 30, 2019	BUY	$12.81 - $25.67 $777,887 - $1.56 Million	60,725 Added 101.97%	120,276 $1.79 Million
Q1 2019 Apr 22, 2019	BUY	$17.66 - $30.28 $2,119 - $3,633	120 Added 0.2%	59,551 $1.48 Million
Q3 2018 Oct 24, 2018	BUY	$29.37 - $49.48 $33,041 - $55,665	1,125 Added 1.93%	59,431 $1.75 Million
Q2 2018 Jul 09, 2018	BUY	$42.06 - $62.4 $435,110 - $645,528	10,345 Added 21.57%	58,306 $2.65 Million
Q1 2018 May 11, 2018	SELL	$50.12 - $67.72 $2.35 Million - $3.18 Million	-46,885 Reduced 49.43%	47,961 $2.53 Million
Q1 2018 Apr 19, 2018	BUY	$50.12 - $67.72 $2.35 Million - $3.18 Million	46,885 Added 97.76%	94,846 $5.01 Million
Q4 2017 Jan 24, 2018	BUY	$57.69 - $84.58 $1.23 Million - $1.8 Million	21,328 Added 80.08%	47,961 $3.26 Million
Q3 2017 Oct 17, 2017	BUY	$67.17 - $84.81 $1.79 Million - $2.26 Million	26,633	26,633 $2.2 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.